Programmed death 1 (PD-1) and cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) are immune check points that negatively regulate T-cell immune function allowing the cancer cells to escape the host immune surveillance. Here, RPL17 is linked to cancer.